|
|
||||||||
The Journal of Immunology, Vol 142, Issue 2 679-687, Copyright © 1989 by American Association of Immunologists
ARTICLES |
KD Brown, SM Zurawski, TR Mosmann and G Zurawski
Department of Molecular Biology, DNAX Research Institute, Palo Alto, CA 94304.
We have isolated and characterized four cDNA clones that encode mRNA expressed more abundantly in Con A-activated mouse helper T cells than by resting T cells. One mRNA encoded a approximately 14-kDa protein with a hydrophobic N-terminal sequence and was abundantly expressed by the Th 2 subset of Th cells, but was not expressed by Th 1 cells. The remaining three mRNA encoded related approximately 8-kDa secreted proteins that are part of a family of small, secreted, and inducible mouse and human proteins. This family of proteins is itself distantly related to another family of growth and inflammatory factors that are associated with various lymphoid and fibroblast activation phenomena. One of the small, inducible, secreted proteins has a predicted mature N terminus identical to that of the previously described macrophage inflammatory protein.
This article has been cited by other articles:
![]() |
D A Vallera, B J Stish, Y Shu, H Chen, A Saluja, D J Buchsbaum, and S M Vickers Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model Gut, May 1, 2008; 57(5): 634 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Katsoulotos, M. Qi, J. C. Qi, K. Tanaka, W. E. Hughes, T. J. Molloy, R. Adachi, R. L. Stevens, and S. A. Krilis The Diacylglycerol-dependent Translocation of Ras Guanine Nucleotide-releasing Protein 4 inside a Human Mast Cell Line Results in Substantial Phenotypic Changes, Including Expression of Interleukin 13 Receptor {alpha}2 J. Biol. Chem., January 18, 2008; 283(3): 1610 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Stish, H. Chen, Y. Shu, A. Panoskaltsis-Mortari, and D. A. Vallera A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer Clin. Cancer Res., November 1, 2007; 13(21): 6486 - 6493. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Shin, Y. H. Kim, B. K. Choi, P. M. Kwon, H.-W. Lee, and B. S. Kwon 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation J. Leukoc. Biol., June 1, 2007; 81(6): 1455 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Bugeja, D R Booth, B H Bennetts, R N. Heard, and G J Stewart An investigation of polymorphisms in the 4q13.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians Multiple Sclerosis, November 1, 2006; 12(6): 710 - 722. [Abstract] [PDF] |
||||
![]() |
N. Y. Yount, K. D. Gank, Y. Q. Xiong, A. S. Bayer, T. Pender, W. H. Welch, and M. R. Yeaman Platelet Microbicidal Protein 1: Structural Themes of a Multifunctional Antimicrobial Peptide Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4395 - 4404. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masuda, Y. Yoshikai, H. Kume, and T. Matsuguchi The Interaction between GATA Proteins and Activator Protein-1 Promotes the Transcription of IL-13 in Mast Cells J. Immunol., November 1, 2004; 173(9): 5564 - 5573. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Xu, M. Wu, J. Hu, Z. Zhai, and H.-B. Shu Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1 J. Leukoc. Biol., August 1, 2002; 72(2): 410 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawakami, M. Kawakami, P. J. Snoy, S. R. Husain, and R. K. Puri In Vivo Overexpression of IL-13 Receptor {alpha}2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice J. Exp. Med., December 17, 2001; 194(12): 1743 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stassen, C. Muller, M. Arnold, L. Hultner, S. Klein-Hessling, C. Neudorfl, T. Reineke, E. Serfling, and E. Schmitt IL-9 and IL-13 Production by Activated Mast Cells Is Strongly Enhanced in the Presence of Lipopolysaccharide: NF-{{kappa}}B Is Decisively Involved in the Expression of IL-9 J. Immunol., April 1, 2001; 166(7): 4391 - 4398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Husain and R. K. Puri Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft Blood, June 1, 2000; 95(11): 3506 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. McKenzie, P. G. Fallon, C. L. Emson, R. K. Grencis, and A. N.J. McKenzie Simultaneous Disruption of Interleukin (IL)-4 and IL-13 Defines Individual Roles in T Helper Cell Type 2-mediated Responses J. Exp. Med., May 17, 1999; 189(10): 1565 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-C. HO, J.I. KIM, S.J. SZABO, and L.H. GLIMCHER Tissue-specific Regulation of Cytokine Gene Expression Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 573 - 584. [Abstract] [PDF] |
||||
![]() |
Y. H. Lai and T. R. Mosmann Mouse IL-13 Enhances Antibody Production In Vivo and Acts Directly on B Cells In Vitro to Increase Survival and Hence Antibody Production J. Immunol., January 1, 1999; 162(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Emson, S. E. Bell, A. Jones, W. Wisden, and A. N.J. McKenzie Interleukin (IL)-4-independent Induction of Immunoglobulin (Ig)E, and Perturbation of T Cell Development in Transgenic Mice Expressing IL-13 J. Exp. Med., July 20, 1998; 188(2): 399 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. de Saint-Vis, I. Fugier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervliet, S. Ait-Yahia, J. Banchereau, Y.-J. Liu, S. Lebecque, and C. Caux The Cytokine Profile Expressed by Human Dendritic Cells Is Dependent on Cell Subtype and Mode of Activation J. Immunol., February 15, 1998; 160(4): 1666 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Salazar-Mather, J. S. Orange, and C. A. Biron Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1{alpha} (MIP-1{alpha})-dependent Pathways J. Exp. Med., January 5, 1998; 187(1): 1 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Godiska, D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, and P. W. Gray Human Macrophage-derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells J. Exp. Med., May 5, 1997; 185(9): 1595 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Welham, L. Learmonth, H. Bone, and J. W. Schrader Interleukin-13 Signal Transduction in Lymphohemopoietic Cells J. Biol. Chem., May 19, 1995; 270(20): 12286 - 12296. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Obiri, W. Debinski, W. J. Leonard, and R. K. Puri Receptor for Interleukin 13 J. Biol. Chem., April 14, 1995; 270(15): 8797 - 8804. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lodi, D. Garrett, J Kuszewski, M. Tsang, J. Weatherbee, W. Leonard, A. Gronenborn, and G. Clore High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR Science, March 25, 1994; 263(5154): 1762 - 1767. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |